Malignant mesothelioma: Canadian perspective and research directions.

about

Malignant mesothelioma: Canadian perspective and research directions.

Item

http://www.wikidata.org/entity/Q47098675

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

2008年學術文章

@zh-hant

name

Malignant mesothelioma: Canadian perspective and research directions.

@en

Malignant mesothelioma: Canadian perspective and research directions.

@nl

type

Item

label

Malignant mesothelioma: Canadian perspective and research directions.

@en

Malignant mesothelioma: Canadian perspective and research directions.

@nl

prefLabel

Malignant mesothelioma: Canadian perspective and research directions.

@en

Malignant mesothelioma: Canadian perspective and research directions.

@nl

P1476

Malignant mesothelioma: Canadian perspective and research directions.

@en

P2093

Baas P

http://www.w3.org/2001/XMLSchema#string

Feld R

http://www.w3.org/2001/XMLSchema#string

Johnston M

http://www.w3.org/2001/XMLSchema#string

Laurie S

http://www.w3.org/2001/XMLSchema#string

Lee CW

http://www.w3.org/2001/XMLSchema#string

MacRae R

http://www.w3.org/2001/XMLSchema#string

Martin J

http://www.w3.org/2001/XMLSchema#string

Murray N

http://www.w3.org/2001/XMLSchema#string

Nguyen E

http://www.w3.org/2001/XMLSchema#string

Shepherd FA

http://www.w3.org/2001/XMLSchema#string

P2860

Malignant Mesothelioma: Global Incidence and Relationship with Asbestos

The European mesothelioma epidemic

Prognostic factors for malignant mesothelioma in 142 patients: validation of CALGB and EORTC prognostic scoring systems

Soluble member(s) of the mesothelin/megakaryocyte potentiating factor family are detectable in sera from patients with ovarian carcinoma

The role of osteopontin in lung disease

Interpretative strategies for lung function tests

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

Adapting the Lung Cancer Symptom Scale (LCSS) to mesothelioma: using the LCSS-Meso conceptual model for validation.

Measuring quality of life in patients with pleural mesothelioma using a modified version of the Lung Cancer Symptom Scale (LCSS): psychometric properties of the LCSS-Meso.

Statement on malignant mesothelioma in the United Kingdom

P304

104-111

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ming-Sound Tsao

P577

2008-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P932

2365488

http://www.w3.org/2001/XMLSchema#string